Physician profile
Julia C Johnson
NPI 1912393109
$1,021.59
in general payments reported to CMS, 2019-2025
21 companies · $431 in 2025
The $431 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.73 · 2020: $56.45 · 2021: $16.68 · 2022: $99.10 · 2023: $182 · 2024: $152 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.63 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142.47 | 2019-2025 | |
| Millicent US INC | $126.10 | 2025 | Intrarosa, Femring, Femlyv |
| Hologic Sales and Service, LLC | $123.81 | 2023-2025 | Thinprep 2000 Processor, Aptima, Third Wave |
| Sumitomo Pharma America, INC. | $116.76 | 2023-2025 | Myfembree |
| Biogen, INC. | $99.09 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $59.10 | 2020-2025 | Paragard T 380a, Endosee |
| Organon LLC | $58.49 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $46.41 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $34.97 | 2022-2025 | |
| Daiichi Sankyo INC. | $31.09 | 2019-2020 | |
| Scynexis, INC. | $22.97 | 2022 | |
| Medtronic, INC. | $22.34 | 2023 | Ligasure |
| Exeltis, USA INC. | $19.79 | 2024 | Slynd |
| Astellas Pharma US INC | $18.70 | 2025 | Veozah |
| Olympus America INC. | $17.37 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.68 | 2021 | |
| Agile Therapeutics, INC. | $15.24 | 2022 | |
| Minerva Surgical, INC | $13.70 | 2020 | |
| Pfizer INC. | $13.13 | 2023 | |
| Covidien LP | $12.52 | 2020 | |
| Allergan, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.